3 ways GLP-1 drugs could be getting better
A race is shaping up among drug manufacturers that are vying to roll out better options when it comes to weight-loss drugs.
A race is shaping up among drug manufacturers that are vying to roll out better options when it comes to weight-loss drugs.
At the American Diabetes Association meeting in New Orleans, market leader Eli Lilly and Co. asserted its dominance in the weight-loss market.
If fulfilled, the proposed agreements signal an end for some potential legal roadblocks to the development of the Citizens-Lebanon Water Supply Program.
The Allen Whitehill Clowes Ballroom is being built adjacent to Clowes Memorial Hall and the Schrott Center for the Arts.
After transforming the treatment of diabetes and weight loss, a growing body of research is raising the possibility that these drugs may help protect against cancer.
The travel center will feature a convenience store, gift shop, extensive food offerings and bathrooms, plus gas pumps and electric vehicle charging stations.